GENFIT Stock Deutsche Boerse AG
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
14:06:15 17/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 11.94 EUR | +2.05% |
|
0.00% | +127.65% |
| 09-15 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 09-15 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
| Market Cap | 588M 675M 557M 506M 945M 64.69B 950M 6.63B 2.56B 32.87B 2.54B 2.48B 105B | P/E 2026 * |
30.3x | P/E 2027 * | 67.1x |
|---|---|---|---|---|---|
| Enterprise Value | 537M 617M 508M 462M 863M 59.07B 867M 6.06B 2.34B 30.02B 2.32B 2.27B 96.09B | EV / Sales 2026 * |
5.36x | EV / Sales 2027 * | 4.1x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| GNFT | Real-time | |
CBOE
| GNFTp | Real-time | |
|
Börse Stuttgart
| XUP | Delayed | |
|
Xetra
| XUP | Delayed | |
|
Tradegate
| XUP | Real-time | |
|
Boerse Muenchen
| XUP | Real-time | |
|
Deutsche Boerse AG
| XUP | Delayed | |
|
London S.E.
| 0QT6 | Delayed | |
|
CBOE
| 0QT6 | Real-time |
Last Transcript: GENFIT
| 1 day | +2.05% | ||
| Current month | -16.50% | ||
| 1 month | -7.73% | ||
| 3 months | +26.62% | ||
| 6 months | +40.80% | ||
| Current year | +127.65% |
| 1 week | 11.7 |  | 12.96 |
| 1 month | 11.7 | | 14.46 |
| Current year | 5.08 | | 14.86 |
| 1 year | 3.01 | | 14.86 |
| 3 years | 2.8 | | 14.86 |
| 5 years | 2.74 | | 14.86 |
| 10 years | 2.74 | | 33.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.05% | 0.00% | - | - | 693M | |
| +1.23% | +1.87% | -0.15% | +9.57% | 45.91B | |
| +0.23% | +4.72% | +44.32% | +27.27% | 44.25B | |
| +0.52% | -3.15% | +349.53% | +520.09% | 41.99B | |
| +1.55% | +3.41% | +6.40% | +76.45% | 39.58B | |
| +1.75% | -0.28% | +12.42% | +41.11% | 31.08B | |
| -0.20% | +5.49% | +23.57% | +119.72% | 17.21B | |
| -3.49% | -8.49% | - | - | 16.27B | |
| +2.92% | +8.40% | +22.46% | +38.87% | 14.96B | |
| -2.45% | +2.41% | -3.16% | -35.16% | 13.42B | |
| Average | +0.41% | +0.77% | +56.93% | +99.74% | 29.41B | |
| Weighted average by Cap. | +0.59% | +0.33% | +72.35% | +120.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 115M 94.91M 86.24M 161M 11.03B 162M 1.13B 437M 5.6B 433M 423M 17.94B | 127M 146M 120M 109M 204M 13.97B 205M 1.43B 554M 7.1B 548M 536M 22.72B |
| Net income | 22.88M 26.27M 21.65M 19.67M 36.75M 2.52B 36.93M 258M 99.72M 1.28B 98.67M 96.48M 4.09B | 9.07M 10.41M 8.58M 7.8M 14.56M 997M 14.64M 102M 39.52M 507M 39.1M 38.23M 1.62B |
| Net Debt | -51.11M -58.68M -48.37M -43.95M -82.1M -5.62B -82.5M -576M -223M -2.86B -220M -216M -9.14B | -67.56M -77.56M -63.94M -58.09M -109M -7.43B -109M -762M -294M -3.78B -291M -285M -12.09B |
| Date | Price | Change |
|---|---|---|
| 17/09/26 | €11.94 | +2.05% |
| 16/09/26 | €11.70 | -6.25% |
| 15/09/26 | €12.48 | -3.70% |
| 14/09/26 | €12.96 | -5.68% |
| 11/09/26 | €13.74 | +15.08% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions
